post-implantation of cardiac resynchronization therapy with defibrillator相关文献:
European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).
Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
Goldenberg I, Hall WJ, Beck CA, Moss AJ, Barsheshet A, McNitt S, Polonsky S, Brown MW, Zareba W.
J Am Coll Cardiol. 2011 Aug 9;58(7):729-37. doi: 10.1016/j.jacc.2011.04.024.
PMID:21816309
Cardiac resynchronization therapy-defibrillator pocket infection caused by Mycobacterium fortuitum: a case report and review of the literature.
Zhu J, Yang Q, Pan J, Shi H, Jin B, Chen Q.
BMC Cardiovasc Disord. 2019 Mar 5;19(1):53. doi: 10.1186/s12872-019-1028-0.
PMID:30836955
Can cardiac resynchronization therapy be used as a tool to reduce sudden cardiac arrest risk?